524632 — Shukra Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for Shukra Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.854	39.7	99.8	121	59.8
Net Total Accounts Receivable
Net Total Receivables	105	327	268	378	252
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	157	531	562	654	838
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	192	219	216	213	336
Long Term Investments
Other Long Term Assets
Total Assets	351	750	778	868	1,174
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	124	425	142	173	231
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	188	497	202	239	276
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	164	253	576	628	898
Total Liabilities & Shareholders' Equity	351	750	778	868	1,174
Total Common Shares Outstanding